{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000174.4:c.2091G>A",
          "cDNA Change": {
            "transcript": "NM_000174.4",
            "ref": "G",
            "alt": "A",
            "position": "2091"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "697"
          },
          "Description in input context": "The SNCA p.Arg697Gln variant was found to be associated with familial Parkinson's disease."
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_000177.3:c.1151G>A",
          "cDNA Change": {
            "transcript": "NM_000177.3",
            "ref": "G",
            "alt": "A",
            "position": "1151"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "384"
          },
          "Description in input context": "The LRRK2 p.Lys384Asn variant was observed in patients exhibiting atypical Parkinsonian features."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003342"
  },
  "Experiment Method": [
    {
      "Assay Method": "Quantitative PCR (qPCR)",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from Parkinson’s Disease patients",
        "Description": "Fibroblasts were obtained from patients diagnosed with familial Parkinson’s disease. Control fibroblasts were also obtained."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000174.4:c.2091G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "The SNCA p.Arg697Gln variant showed increased α-synuclein mRNA levels compared to control fibroblasts."
        },
        {
          "Variant": "NM_000177.3:c.1151G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "The LRRK2 p.Lys384Asn variant showed reduced LRRK2 protein levels."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated with fibroblasts from three independent patients with the SNCA mutation and two patients with the LRRK2 mutation."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each qPCR reaction was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type control fibroblasts were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No template control was included to verify the specificity of the PCR primers."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare mRNA levels between patients and controls."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "mRNA levels within the range observed in age-matched controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "mRNA levels significantly higher than those observed in age-matched controls (p < 0.05).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}